Analysis of the Genotypes in a Chinese Population with Increased Hb A₂ and Low Hematological Indices

References

• Li J, Xie XM, Liao C, et al. Co-inheritance of α-thalassaemia and β-thalassaemia in a prenatal screening population in mainland China. J Med Screen. 2014;21(4):167–171.
   PubMed Web of Science ®Google Scholar
• Li J, Yan JM, Xie XM, et al. Consequences of delayed prenatal diagnosis of β-thalassemia in Mainland China. Hemoglobin 2016;40(3):191–193.
   PubMed Web of Science ®Google Scholar
• Jiang F, Chen GL, Li J, et al. Pre gestational thalassemia screening in Mainland China: the first two years of a preventive program. Hemoglobin. 2017;41(4-6):248–253.
   PubMed Web of Science ®Google Scholar
• Mosca A, Paleari R, Ivaldi G, et al. The role of Haemoglobin A2 testing in the diagnosis of thalassaemias and related haemoglobinopathies. J Clin Pathol. 2009;62(1):13–17.
   PubMed Web of Science ®Google Scholar
• Keren DF, Hedstrom D, Gulbranson R, et al. Comparison of Sebia Capillarys capillary electrophoresis with the Primus high-pressure liquid chromatography in the evaluation of hemoglobinopathies. Am J Clin Pathol. 2008;130(5):824–831.
   PubMed Web of Science ®Google Scholar
• He P, Yan Y, Li R, et al. Prenatal control of Hb Bart’s disease in mainland China: can we do better. J Med Screen. 2014;21(4):167–171.
   PubMed Web of Science ®Google Scholar
• Li J, Li R, Li DZ. Identification of nondeletional α-thalassemia in a prenatal screening program by reverse dot-blot in southern China. Hemoglobin. 2015;39(1):42–45.
   PubMed Web of Science ®Google Scholar
• Li D, Liao C, Li J, et al. Prenatal diagnosis of β-thalassemia by reverse dot-blot hybridization in southern China. Hemoglobin 2006;30(3):365–370.
   PubMed Web of Science ®Google Scholar
• Giambona A, Passarello C, Renda D, Maggio A. The significance of the Hemoglobin A2 value in screening for hemoglobinopathies. Clin Biochem. 2009;42(18):1786–1796.
   PubMed Web of Science ®Google Scholar
• Xu XM, Zhou YQ, Luo GX, et al. The prevalence and spectrum of α and β thalassaemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol. 2004;57(5):517–522.
   PubMed Web of Science ®Google Scholar
• Fucharoen S, Winichagoon P, Thonglairuam V. β-thalassemia associated with α-thalassemia in Thailand. Hemoglobin. 1988;12(5-6):581–592.
   PubMed Web of Science ®Google Scholar
• Lam YH, Ghosh A, Tang MH, et al. The risk of α-thalassaemia in offspring of β-thalassaemia carriers in Hong Kong. Prenat Diagn. 1997;17(8):733–736.
   PubMed Web of Science ®Google Scholar
• Kwan Ma ES, Yin Chan AY, Yin Ha S, et al. Screening for (-SEA) alpha-globin gene deletion in beta-thalassemia carriers and prevention of hydrops fetalis. Haematologica. 2000;85(9):991–993.
   PubMed Web of Science ®Google Scholar
• Kanavakis E, Wainscoat JS, Wood WG, et al. The interaction of α thalassaemia with heterozygous β thalassaemia. Br J Haematol. 1982;52(3):465–473.
   PubMed Web of Science ®Google Scholar
• Melis MA, Pirastu M, Galanello R, et al. Phenotypic effect of heterozygous α and β-thalassemia interaction. Blood. 1983;62(1):226–229.
   PubMed Web of Science ®Google Scholar
• Rosatelli C, Falchi AM, Scalas MT, et al. Hematological phenotype of the double heterozygous state for α- and β-thalassemia. Hemoglobin. 1984;8(1):25–35.
   PubMed Web of Science ®Google Scholar
• Yin XL, Wu ZK, Zhou XY, et al. Co-inherited β-thalassemia trait and Hb H disease: clinical characteristics and interference in diagnosis of thalassemia by high-performance liquid chromatography. Int J Lab Hematol. 2012;34(4):427–431.
   PubMed Web of Science ®Google Scholar
• Lou JW, Li DZ, Zhang Y, et al. Delineation of the molecular basis of borderline Hemoglobin A2 in Chinese individuals. Blood Cells Mol Dis. 2014;53(4):261–264.
   PubMed Web of Science ®Google Scholar
• Giambona A, Passarello C, Vinciguerra M, et al. Significance of borderline Hemoglobin A2 values in an Italian population with a high prevalence of β-thalassemia. Haematologica 2008;93(9):1380–1384.
   PubMed Web of Science ®Google Scholar
• Galanello R, Barella S, Ideo A, et al. Genotype of subjects with borderline Hemoglobin A2 levels: implication for β-thalassemia carrier screening . Am J Hematol. 1994;46(2):79–81.
   PubMed Web of Science ®Google Scholar
• Paglietti ME, Satta S, Sollaino MC, et al. The problem of borderline Hemoglobin A2 levels in the screening for β-thalassemia carriers in Sardinia. Acta Haematol. 2016;135(4):193–199.
   PubMed Web of Science ®Google Scholar
• Perseu L, Satta S, Moi P, et al. KLF1 gene mutations cause borderline HbA(2). Blood. 2011;118(16):4454–4458.
   PubMed Web of Science ®Google Scholar
• Ryan K, Bain BJ, Worthington D, et al. British Committee for Standards in Haematology. Significant haemoglobinopathies: guidelines for screening and diagnosis. Br J Haematol. 2010;149(1):35–49.
   PubMed Web of Science ®Google Scholar
• Cai WJ, Li J, Xie XM, et al. Screening for common β-globin gene cluster deletions in Chinese individuals with increased Hemoglobin F. Int Jnl Lab Hem. 2015;37(6):752–757.
   PubMed Web of Science ®Google Scholar
• Liao C, Feng Q, Li J, et al. double heterozygote for (δβ)0-thalassemia and codons 41/42 (–TTCT) behaves as a homozygote for the frameshift mutation in a Chinese family. Hemoglobin. 2007;31(3):397–400.
   PubMed Web of Science ®Google Scholar
• Chen W, Zhang X, Shang X, et al. The molecular basis of β-thalassemia intermedia in southern China: genotypic heterogeneity and phenotypic diversity. BMC Med Genet. 2010;11(1):31.
   PubMed Web of Science ®Google Scholar
• Peng CT, Liu SC, Chiou SS, et al. Molecular characterization of deletional forms of β-thalassemia in Taiwan. Ann Hematol. 2003;82(1):33–36.
   PubMed Web of Science ®Google Scholar
• Old J, Harteveld CL, Traeger-Synodinos J, et al. Prevention of Thalassaemias and Other Haemoglobin Disorders, Vol. 2. Laboratory Protocols [Internet]. 2nd ed. Nicosia, Cyprus: Thalassaemia International Federation, 2012.
   Google Scholar